Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
| continuous remote monitoring of a physiologic signal | The overnight telemetry strip captured the episode. | Objective | Cardiac imaging, hemodynamics and rhythm details | |
tilt-table testing | monitoring blood pressure and pulse while the table angle changes | Arrange tilt-table testing and include the circumstances of prior episodes. | Plan | Perioperative, diagnostic and follow-up actions |
time in range | percentage of monitored glucose readings or time within specified bounds | The sensor report lists time in range for the displayed targets. | Objective | Electrolytes, acid-base and metabolic testing |
vancomycin | glycopeptide antibiotic measured for exposure monitoring in selected settings | The vancomycin report lists a measured concentration and a separate estimated AUC24. | Objective | Drug levels - named analytes and exposure reports |
voriconazole | azole antifungal with selected use of trough monitoring | The voriconazole concentration is labeled with dose route and collection time. | Objective | Drug levels - named analytes and exposure reports |
1,25-dihydroxyvitamin D | active vitamin D metabolite measured for a specific clinical question | 1,25-dihydroxyvitamin D was reviewed with kidney function and calcium balance. | Objective | Glucose monitoring, endocrine testing and urine studies |
25-hydroxyvitamin D | circulating vitamin D metabolite commonly used to assess vitamin D status | 25-hydroxyvitamin D was reported separately from the active vitamin D metabolite. | Objective | Glucose monitoring, endocrine testing and urine studies |
acknowledgment | confirmation that the intended recipient received the information | Record acknowledgment of the result by the covering pharmacist. | Plan | Monitoring actions, escalation and result communication |
ACTH stimulation test | cortisol response measured before and after administration of synthetic ACTH | The ACTH stimulation test was reported with the assay and sampling schedule. | Objective | Glucose monitoring, endocrine testing and urine studies |
adherence assessment | open review of what the person has actually been able to take | Include access, missed doses and timing in the adherence assessment. | Plan | Monitoring actions, escalation and result communication |
aldosterone-renin ratio | aldosterone concentration divided by a stated renin measure | The aldosterone-renin ratio was recorded with units, posture and relevant medicines. | Objective | Glucose monitoring, endocrine testing and urine studies |
apnea | period of absent airflow | A period of apnea is recorded during sleep monitoring. | Objective | Respiratory examination and ventilation |
arrhythmia | abnormal cardiac rhythm | The monitor captured an arrhythmia during the reported symptoms. | Objective | Tracings, rhythm and diagnostic measurements |
assess | evaluate a problem or ability | Assess standing balance at the next therapy visit. | Plan | Investigation and monitoring |
baseline comparison | comparison with the patient's own prior measure | Use the last stable outpatient result for baseline comparison. | Plan | Monitoring actions, escalation and result communication |
C-peptide | peptide released with endogenous insulin and used to assess endogenous insulin production | C-peptide was interpreted with the paired glucose and kidney function. | Objective | Glucose monitoring, endocrine testing and urine studies |
calendar date | date attached to an event or measurement | Record the calendar date for each dose when interpreting overnight samples. | Plan | Monitoring actions, escalation and result communication |
capillary glucose | glucose measured in a capillary blood specimen | Capillary glucose was documented with time and relation to the meal. | Objective | Glucose monitoring, endocrine testing and urine studies |
characterize | describe the distinguishing features | Characterize the episodes by duration, triggers, and recovery. | Plan | Investigation and monitoring |
| resolve a specific uncertainty | Clarify the timing of the rash relative to the first dose. | Plan | Investigation and monitoring | |
clinical reassessment | repeat evaluation of symptoms, signs and current condition | Arrange clinical reassessment when the result becomes available. | Plan | Monitoring actions, escalation and result communication |
closed-loop communication | communication with confirmation of receipt and assigned action | Use closed-loop communication for the amended critical result. | Plan | Monitoring actions, escalation and result communication |
coefficient of variation for glucose | glucose standard deviation expressed as a percentage of mean glucose | Coefficient of variation for glucose was calculated for the specified sensor-report period. | Objective | Glucose monitoring, endocrine testing and urine studies |
| take a sample for testing | Collect a urine specimen for the requested culture. | Plan | Investigation and monitoring | |
| review two results side by side | Compare today's tracing with the prior electrocardiogram. | Plan | Investigation and monitoring |